Sysmex Cash Flow | StatInvestor

Health Care & Life Sciences » Medical Equipment & Supplies | Sysmex Corp.

Sysmex Corp. | Cash Flow

Fiscal year is April-March. All values JPY Millions.

2014

2015

2016

2017

2018

2019

Net Income before Extraordinaries

33,451

45,727

57,809

48,946

58,117

57,955

Depreciation, Depletion & Amortization

11,395

12,953

12,110

12,381

14,643

15,842

Other Funds

148

15,564

Funds from Operations

34,427

46,312

50,841

45,747

61,116

58,235

Changes in Working Capital

2,136

7,672

9,047

12,915

8,876

13,492

Net Operating Cash Flow

36,563

38,640

41,794

32,832

52,240

44,743

Capital Expenditures

17,094

16,488

22,084

19,106

25,695

Sale of Fixed Assets & Businesses

268

107

200

140

Purchase/Sale of Investments

2,339

633

632

375

Net Investing Cash Flow

33,940

19,544

23,850

19,400

37,828

Cash Dividends Paid - Total

4,544

6,734

9,549

11,646

12,493

Issuance/Reduction of Debt, Net

780

1,205

Net Financing Cash Flow

2,897

7,554

8,755

10,866

11,545

Net Change in Cash

2,240

13,672

6,869

1,464

3,500

Free Cash Flow

23,281

25,607

28,109

21,150

35,667

Net Assets from Acquisitions

16,643

341

403

1,453

11,672

Other Sources

1,930

Change in Capital Stock

867

385

849

928

1,036

Exchange Rate Effect

2,514

2,130

2,320

1,102

633

Other Uses

409

467

836

338

226

About Sysmex

View Profile

Address	1-5-1 Wakinohama-Kaigandori Kobe Hyogo 651 Japan
Employees	-
Website	http://www.sysmex.co.jp
Updated	07/08/2019
Sysmex Corp. engages in the development, manufacture, import, export, and sale of clinical laboratory instruments, reagents, and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing.